These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29457969)

  • 1. An evaluation of the operational model when applied to quantify functional selectivity.
    Zhu X; Finlay DB; Glass M; Duffull SB
    Br J Pharmacol; 2018 May; 175(10):1654-1668. PubMed ID: 29457969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intact model for quantifying functional selectivity.
    Zhu X; Finlay DB; Glass M; Duffull SB
    Sci Rep; 2019 Feb; 9(1):2557. PubMed ID: 30796256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for the quantification of biased signalling at constitutively active receptors.
    Hall DA; Giraldo J
    Br J Pharmacol; 2018 Jun; 175(11):2046-2062. PubMed ID: 29498414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling and simulation of biased agonism dynamics at a G protein-coupled receptor.
    Bridge LJ; Mead J; Frattini E; Winfield I; Ladds G
    J Theor Biol; 2018 Apr; 442():44-65. PubMed ID: 29337260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Complementary Scale of Biased Agonism for Agonists with Differing Maximal Responses.
    Burgueño J; Pujol M; Monroy X; Roche D; Varela MJ; Merlos M; Giraldo J
    Sci Rep; 2017 Nov; 7(1):15389. PubMed ID: 29133887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Being mindful of seven-transmembrane receptor 'guests' when assessing agonist selectivity.
    Kenakin T
    Br J Pharmacol; 2010 Jul; 160(5):1045-7. PubMed ID: 20590598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASAS-NANP symposium: Mathematical Modeling in Animal Nutrition: The power of identifiability analysis for dynamic modeling in animal science:a practitioner approach.
    Muñoz-Tamayo R; Tedeschi LO
    J Anim Sci; 2023 Jan; 101():. PubMed ID: 37997927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parametric sensitivity analysis for biochemical reaction networks based on pathwise information theory.
    Pantazis Y; Katsoulakis MA; Vlachos DG
    BMC Bioinformatics; 2013 Oct; 14():311. PubMed ID: 24148216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing parameter identifiability in compartmental dynamic models using a computational approach: application to infectious disease transmission models.
    Roosa K; Chowell G
    Theor Biol Med Model; 2019 Jan; 16(1):1. PubMed ID: 30642334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications and limitations of fitting of the operational model to determine relative efficacies of agonists.
    Jakubík J; Randáková A; Rudajev V; Zimčík P; El-Fakahany EE; Doležal V
    Sci Rep; 2019 Mar; 9(1):4637. PubMed ID: 30874590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operational models of pharmacological agonism.
    Black JW; Leff P
    Proc R Soc Lond B Biol Sci; 1983 Dec; 220(1219):141-62. PubMed ID: 6141562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifiability analysis for stochastic differential equation models in systems biology.
    Browning AP; Warne DJ; Burrage K; Baker RE; Simpson MJ
    J R Soc Interface; 2020 Dec; 17(173):20200652. PubMed ID: 33323054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical re-evaluation of the slope factor of the operational model of agonism: When to exponentiate operational efficacy.
    Randáková A; Nelic D; Jakubík J
    Sci Rep; 2023 Oct; 13(1):17587. PubMed ID: 37845324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data.
    Stott LA; Hall DA; Holliday ND
    Biochem Pharmacol; 2016 Feb; 101():1-12. PubMed ID: 26478533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural identifiability analysis of pharmacokinetic models using DAISY: semi-mechanistic gastric emptying models for 13C-octanoic acid.
    Ogungbenro K; Aarons L
    J Pharmacokinet Pharmacodyn; 2011 Apr; 38(2):279-92. PubMed ID: 21347679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased ligand quantification in drug discovery: from theory to high throughput screening to identify new biased μ opioid receptor agonists.
    Winpenny D; Clark M; Cawkill D
    Br J Pharmacol; 2016 Apr; 173(8):1393-403. PubMed ID: 26791140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical structural identifiability methodology applied to low-dimensional dynamic systems in receptor theory.
    White C; Rottschäfer V; Bridge L
    J Pharmacokinet Pharmacodyn; 2024 Feb; 51(1):39-63. PubMed ID: 37389744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parameter identifiability analysis and visualization in large-scale kinetic models of biosystems.
    Gábor A; Villaverde AF; Banga JR
    BMC Syst Biol; 2017 May; 11(1):54. PubMed ID: 28476119
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.